open access

Vol 11, No 2 (2005)
Original papers
Published online: 2005-05-19
Get Citation

The usefulness of assessing the serum levels of homocysteine in diagnosis of atherosclerosis

Danuta Kokocińska, Lech Cierpka, Bogdan Chmiel, Marian Duraj, Robert Partyka, Szymon Cierpka, Jacek Kocot, Piotr Wieczorek
Acta Angiologica 2005;11(2):114-120.

open access

Vol 11, No 2 (2005)
Original papers
Published online: 2005-05-19

Abstract

Background. Cardiovascular diseases are the most common cause of death in Poland. Homocystein has recently been added to the list of atherosclerosis risk factors. Homocystein is an amino acid, which contains sulphur. Homocysteine is toxic for the endothelium. The aim of the study was to assess the plasma levels of the homocysteine in patients with clinical symptoms of atherosclerosis.
Material and methods. Sixty-eight patients including 26 with lower extremities atherosclerosis, 10 after CABG, 10 with AMI, 15 with ischemic stroke, 4 with abdominal aortic aneurysm and 3 with renal artery obstruction were enrolled. Patients suffering from acute MI or stroke, kidney failure, autoimmune diseases and neoplasms were excluded from the investigation. Thirty healthy volunteers were the control group.
Results. Homocysteine levels in all patient groups were higher than in the control group except patients with abdominal aortic aneurysm. The highest homocysteine concentrations (29.2 ± 11.32 µmol/l; p < 0.001) were in patients after CABG.
Conclusions. homocysteine is an important, independent cardiovascular diseases risk factor and should be routinely examined for in patients with other risk factors.

Abstract

Background. Cardiovascular diseases are the most common cause of death in Poland. Homocystein has recently been added to the list of atherosclerosis risk factors. Homocystein is an amino acid, which contains sulphur. Homocysteine is toxic for the endothelium. The aim of the study was to assess the plasma levels of the homocysteine in patients with clinical symptoms of atherosclerosis.
Material and methods. Sixty-eight patients including 26 with lower extremities atherosclerosis, 10 after CABG, 10 with AMI, 15 with ischemic stroke, 4 with abdominal aortic aneurysm and 3 with renal artery obstruction were enrolled. Patients suffering from acute MI or stroke, kidney failure, autoimmune diseases and neoplasms were excluded from the investigation. Thirty healthy volunteers were the control group.
Results. Homocysteine levels in all patient groups were higher than in the control group except patients with abdominal aortic aneurysm. The highest homocysteine concentrations (29.2 ± 11.32 µmol/l; p < 0.001) were in patients after CABG.
Conclusions. homocysteine is an important, independent cardiovascular diseases risk factor and should be routinely examined for in patients with other risk factors.
Get Citation

Keywords

homocysteine; atherosclerosis; intermittent claudication; coronary artery bypass; myocardial infarction; brain infarction; renal artery obstruction; aortic aneurysm; abdominal

About this article
Title

The usefulness of assessing the serum levels of homocysteine in diagnosis of atherosclerosis

Journal

Acta Angiologica

Issue

Vol 11, No 2 (2005)

Pages

114-120

Published online

2005-05-19

Bibliographic record

Acta Angiologica 2005;11(2):114-120.

Keywords

homocysteine
atherosclerosis
intermittent claudication
coronary artery bypass
myocardial infarction
brain infarction
renal artery obstruction
aortic aneurysm
abdominal

Authors

Danuta Kokocińska
Lech Cierpka
Bogdan Chmiel
Marian Duraj
Robert Partyka
Szymon Cierpka
Jacek Kocot
Piotr Wieczorek

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl